# Jaguar Health (JAGX) — Earnings

JAGX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/jagx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$235.50 |
| EPS estimate | −$782.25 |
| EPS surprise | +69.89% |
| Revenue surprise | −71.11% |
| Revenue | $1.2M |
| Revenue estimate | $4.2M |
| Reported | Aug 19, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1585608/000119312526356570/jagx-20260630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 19, 2026 | −$782.25 | −$235.50 | 69.89% | $4.2M | $1.2M |
| Q3 2025 | Nov 14, 2025 | −$2,667.00 | −$3,297.00 | -23.62% | $3.7M | $3.1M |
| Q2 2025 | Aug 14, 2025 | −$3,743.25 | −$5,386.50 | -43.90% | $3.3M | $3.0M |
| Q1 2025 | May 15, 2025 | −$5,680.50 | −$8,767.50 | -54.34% | $2.8M | $2.2M |
| Q4 2024 | Mar 31, 2025 | −$9,712.50 | −$7,728.00 | 20.43% | $3.1M | $3.5M |
| Q3 2024 | Nov 13, 2024 | −$31,106.25 | −$13,781.25 | 55.70% | $3.9M | $3.1M |
| Q2 2024 | Aug 13, 2024 | −$15,805.12 | −$53,025.00 | -235.49% | $3.4M | $2.7M |
| Q1 2024 | May 14, 2024 | −$23,625.00 | −$47,250.00 | -100.00% | $3.0M | $2.4M |
| Q4 2023 | Apr 1, 2024 | −$771,749.93 | $1,102,499.90 | 242.86% | $2.6M | $2.3M |
| Q3 2023 | Nov 14, 2023 | −$968,624.91 | −$299,249.97 | 69.11% | $2.5M | $2.8M |
| Q2 2023 | Aug 14, 2023 | −$1,204,874.89 | −$330,749.97 | 72.55% | $2.3M | $2.7M |
| Q1 2023 | May 15, 2023 | −$3,543,749.67 | −$1,882,124.83 | 46.89% | $3.9M | $2.0M |
| Q3 2022 | Nov 14, 2022 | −$4,429,687.09 | −$7,087,499.34 | -60.00% | $3.5M | $3.1M |
| Q2 2022 | Aug 22, 2022 | −$12,993,748.80 | −$7,087,499.34 | 45.45% | $3.1M | $2.9M |
| Q1 2022 | May 10, 2022 | −$10,335,936.54 | −$23,624,997.81 | -128.57% | $1.6M | $2.6M |
| Q4 2021 | Mar 11, 2022 | −$5,315,624.51 | −$18,309,373.31 | -244.44% | $8.4M | $2.1M |
| Q3 2021 | Nov 17, 2021 | −$13,879,686.22 | −$15,946,873.53 | -14.89% | $1.4M | $630,000.00 |
| Q2 2021 | Aug 13, 2021 | −$7,087,499.34 | −$17,718,748.36 | -150.00% | $5.0M | $385,000.00 |
| Q1 2021 | May 17, 2021 | −$3,543,749.67 | −$17,718,748.36 | -400.00% | $7.4M | $1.2M |
| Q3 2020 | Nov 16, 2020 | −$19,490,623.20 | −$37,209,371.56 | -90.91% | $7.8M | $2.8M |

## Frequently Asked Questions

### When did Jaguar Health (JAGX) last report earnings?

Jaguar Health last reported on Aug 19, 2026, covering fiscal Q2 2026.

### Did JAGX beat earnings estimates?

Yes. Jaguar Health reported EPS of −$235.50 for Q2 2026 against a −$782.25 estimate — a 69.89% beat.

### How much revenue did JAGX report last quarter?

Jaguar Health reported $1.2M in revenue for Q2 2026, against a consensus estimate of $4.2M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).